Imiquimod Does not Affect Shedding of Viable Chlamydiae in a
Murine Model of Chlamydia trachomatis Genital Tract Infection

Kyle H. Ramsey; Namir Shaba; Kevin P. Cohoon; Kevin A. Ault

doi:10.1080/10647440300025503

Infectious Diseases in Obstetrics and Gynecology (Jan 2003)

Imiquimod Does not Affect Shedding of Viable Chlamydiae in a Murine Model of Chlamydia trachomatis Genital Tract Infection

Kyle H. Ramsey,
Namir Shaba,
Kevin P. Cohoon,
Kevin A. Ault

Affiliations

Kyle H. Ramsey: Department of Microbiology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, Downers Grove, IL 60515, USA
Namir Shaba: Department of Microbiology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, Downers Grove, IL 60515, USA
Kevin P. Cohoon: Department of Microbiology, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st Street, Downers Grove, Downers Grove, IL 60515, USA
Kevin A. Ault: Department of Obstetrics and Gynecology, University of Iowa College of Medicine, Iowa City, IA, USA

DOI: https://doi.org/10.1080/10647440300025503
Journal volume & issue: Vol. 11, no. 2
pp. 81 – 87

Abstract

Read online

Objective: We postulated that either oral or vaginal administration of the immune response modifier imiquimod would decrease vaginal shedding of Chlamydia trachomatis, mouse pneumonitis strain (MoPn), in a murine model.

Published in Infectious Diseases in Obstetrics and Gynecology

ISSN: 1064-7449 (Print); 1098-0997 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Gynecology and obstetrics; Medicine: Internal medicine: Infectious and parasitic diseases
Website: https://www.hindawi.com/journals/idog/

About the journal